Cedars-Sinai care teams now have a new AI tool that brings the latest medical evidence into the context of each patient's own record, helping inform diagnosis and treatment at the moment of care. Learn more: https://ceda.rs/43GGHSB

Cedars-Sinai investigators developed a hospital screening method that catches undiagnosed cognitive impairment and dementia in older adults at admission, giving care teams more time to plan safer stays and discharge. Learn more: https://ceda.rs/3PzX1kR

Every patient is someone’s family. Internal medicine resident Cymac “Mac” Heravian, MD shares how mentorship, teamwork and a culture of service shape residency training at Cedars-Sinai.

Mapping gene activity across a tumor can take weeks and cost thousands of dollars. Cedars-Sinai-led investigators built Path2Space to do it from existing biopsy slides in minutes, for far less. With more testing, it could help bring personalized cancer care to more people. https://ceda.rs/4vb7DpI

A BRCA mutation can mean up to a dozen separate cancer screenings, each its own appointment. The new Cedars-Sinai Cayton BRCA Center, opening in early July, brings them into a single coordinated visit. Learn more: https://ceda.rs/4w326l2

New early-stage Cedars-Sinai research tested a dialysis-like treatment that filters sFlt-1, a placental protein driving preeclampsia, lengthening pregnancy by about 10 days in a small study. The approach is experimental and needs larger trials. Learn more: https://ceda.rs/4t7a6Qi

Cedars-Sinai investigators are joining a $9 million multi-institutional effort to clarify how pesticide exposure and genetics drive Parkinson's disease, using lab-grown neurons from affected families to study the biology behind the condition. Learn more: https://ceda.rs/4ouv76C 🔬

Transcatheter tricuspid valve replacement delivered strong early outcomes in real-world care, with meaningful improvement in symptoms and quality of life within 30 days. Learn more about the national study was led by Cedars-Sinai investigators: https://ceda.rs/4v9kY1J

Congratulations to the Cedars-Sinai Health Sciences University Class of 2026. Graduates of the Graduate School of Biomedical Sciences & the inaugural class of the Chuck Lorre School of Allied Health carry their compassion, skill & resilience into careers that strengthen patient care and communities.

The American Academy of Arts and Sciences has honored Cedars-Sinai president and CEO emeritus Thomas M. Priselac for more than three decades of nonprofit leadership. Learn more: https://ceda.rs/4difqub

A sudden cardiac episode on a bridge sent Maria Dondero searching for the right heart team. She found it at the Smidt Heart Institute at Cedars-Sinai, where surgeons repair more than 99% of mitral valves like hers. Read her story: https://ceda.rs/4fhzsHY

Training at Cedars-Sinai means learning in one of the most dynamic clinical environments in the country. Eman Dadashian, MD, a fourth-year urology resident, shares how diverse patient care, leading researchers and advanced surgical technology help shape the next generation of physicians.

Agentic AI can interpret data, report results and make decisions on its own. Jason Moore, PhD, chair of the Department of Computational Biomedicine at Cedars-Sinai, explores what that means for the future of discovery. Read more: https://ceda.rs/49ZRUkK @moorejh.bsky.social

Heart disease is the leading cause of death among breast cancer survivors. New findings in npj Breast Cancer examine how race and income relate to long-term heart failure risk, pointing to where closer monitoring could help most. Learn more: https://ceda.rs/3PzX1kR

Investigators at the Smidt Heart Institute at Cedars-Sinai are expanding the heart transplant donor pool by advancing how organs are preserved and transported, helping teams use hearts that would once have been out of reach. Learn more: https://ceda.rs/4fNc0T0

A study led by Cedars-Sinai Health Sciences University offers the most comprehensive look yet at the long-term safety of medications used to manage irritable bowel syndrome, pointing to the need for more personalized care. Learn more: https://ceda.rs/4nVO6a

The latest research tip sheet from Cedars-Sinai brings together recent findings from investigators across cardiology, pharmacy, oncology and cellular biology. Click to learn more: https://ceda.rs/42JbhdR

Cedars-Sinai Clinic London has opened in the Harley Street Health District, the institution's first flagship outpatient clinic outside the U.S. It connects U.K. patients to coordinated care with Cedars-Sinai in Los Angeles. Learn more: https://ceda.rs/4uiTnuF

Cedars-Sinai investigators are studying how to reverse damage to the brain and spinal cord. Their early-stage research spans neuroprosthetic control, spinal cord repair and cognitive decline, all working toward recovering lost movement and memory. Learn more: https://ceda.rs/3Re6xuo

Research Day at Cedars-Sinai is bringing our community together to share discoveries that reach from basic science to bedside care, all of it focused on the patient. The breadth of work on display, and the chance to connect and exchange ideas, is what we look forward to every year.

Research Day at Cedars-Sinai is bringing our community together to share discoveries that reach from basic science to bedside care, all of it focused on the patient. The breadth of work on display, and the chance to connect and exchange ideas, is what we look forward to every year.

Cedars-Sinai EMT program students share what it takes to become a confident EMT in the field, from classroom instruction to clinical rotations and ride-alongs across Los Angeles. Hear more about the student experience and explore the program: https://ceda.rs/48ptYUX

Cedars-Sinai investigators are sending organ models to the International Space Station to study inflammaging, the chronic inflammation behind many age-related diseases. The work could speed the search for therapies that protect health on Earth. Learn more: https://ceda.rs/4uPy57L

A discovery arc spanning more than two decades at Cedars-Sinai has carried the cardiosphere-derived cell research of Eduardo Marbán, MD, PhD, and his team from first isolation to a candidate therapy now under FDA review. Read more: https://ceda.rs/4v8AT07

Cedars-Sinai neurosurgeon Nestor Gonzalez, MD, helped develop the new American Heart Association and American Stroke Association stroke guidelines. The updates broaden eligibility for advanced treatment and introduce dedicated guidance for pediatric stroke care. Learn more: https://ceda.rs/4u86Fdo

The gut microbiome may offer a simpler way to check colon cancer risk in patients with ulcerative colitis. Cedars-Sinai investigators co-led a study linking chemical signals from gut microbes to tumor growth, pointing to a new path for screening and prevention. Learn more: https://ceda.rs/3QTEyA1

Clinical trials are where discovery becomes practice. Today we recognize the patients, researchers and clinicians who turn questions into answers and bring innovative care closer to the people who need it. Learn more about clinicial trials at Cedars-Sinai: https://ceda.rs/44tq24L

Cedars-Sinai researchers are using AI to study surgical video frame by frame, linking the small choices surgeons make during an operation to how patients recover later. The work is helping turn surgery into a practice that can be measured, studied and taught. Learn more: https://ceda.rs/4vW7583

Cedars-Sinai researchers documented a sharp rise in heart attacks and respiratory ER visits in Los Angeles following the January 2025 wildfires. The study, led by Susan Cheng, MD, points to wildfire smoke as a likely trigger for acute cardiovascular events. Read the Q&A: https://ceda.rs/4tfGZKt

Cedars-Sinai investigators developed a new MRI system that can noninvasively measure how efficiently the heart uses oxygen, an early indicator of heart failure. The advance could support earlier detection and new approaches to heart failure care. Learn more: https://ceda.rs/4mLchrj

Cedars-Sinai's 12-week Certificate in Applied AI for Health Systems is fully online and requires no technical background, designed for healthcare professionals applying AI in clinical, operational and research settings. Reserve your spot for the June 15 cohort: https://ceda.rs/47RYKXz

Cedars-Sinai investigators are mapping Type 2 diabetes at the tissue level of the duodenum using AI, spatial transcriptomics and digital pathology to identify molecular signatures of metabolic disease and explore regenerative endoscopy approaches. Read more: https://ceda.rs/42mgdFm

Cedars-Sinai investigators have identified blood biomarkers that could support earlier detection of cachexia, or cancer wasting syndrome, in patients with advanced lung cancer. The findings could inform future risk assessment and shape new therapies. Learn more: https://ceda.rs/4e8XaWn

New Cedars-Sinai research reveals how transplanted neural stem cells interact with host retinal cells to preserve vision in models of retinitis pigmentosa, pointing toward future strategies for degenerative eye disease. Learn more: https://ceda.rs/4e8XaWn

New findings from Cedars-Sinai and collaborators could reshape how researchers approach treatment for multiple sclerosis. Published across two complementary studies in Nature, the work points to a potential new target for protecting the brain. Learn more: https://ceda.rs/4uqSH6g

Ravi Thadhani, MD, MPH, has been elected a Fellow of the American Association for the Advancement of Science for his contributions to clinical and translational research in nephrology and maternal health. Learn more: https://ceda.rs/3NDQW61

New from Cedars-Sinai: Significant fluid balance shifts after elective cardiac surgery are associated with ICU readmission, longer stays and higher mortality across 2,500+ patients studied. Read more from our latest Research Tip Sheet: https://ceda.rs/4btzrNx

Jayson Flores joined Cedars-Sinai through Environmental Services and is now training to become a pharmacy technician at Chuck Lorre Allied Health School. If a career in pharmacy interests you, applications for the next cohort are open through May 31: https://ceda.rs/4lpqQyN

Cedars-Sinai Cancer is working directly with the communities it serves to advance research, prevention and early detection. We are partnering with patients, survivors and community leaders to shape research priorities and expand access to screening. Learn more: https://ceda.rs/4mRHede

Cedars-Sinai Health Sciences University investigators have identified a protein that acts as a "dimmer switch" to calm overactive immune responses and limit harmful inflammation. Learn more about the research: https://ceda.rs/4e8XaWn

AI is transforming healthcare. Those who know how to apply it will pull ahead. The Cedars-Sinai Master of Science in Health Systems trains professionals in applied AI, digital health, and health systems science to drive real change. Apply by May 29: https://ceda.rs/4czF3Gj

Cedars-Sinai investigators are reframing delirium as acute brain failure, a serious and modifiable risk factor for long-term cognitive decline that affects tens of millions of hospitalized patients each year. Learn more: https://ceda.rs/4u1PF8a

Cedars-Sinai Cancer's same-day multidisciplinary clinics are changing how complex cases move from diagnosis to treatment plan. Subspecialists, advanced diagnostics and treatment planning come together in a single coordinated visit. Learn more: https://ceda.rs/4tTs0Xy

Susan Cheng, MD, MMSc, MPH, has been appointed chair of the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai. The clinician-scientist will lead clinical, research and educational growth across the department. Learn more: https://ceda.rs/4sxzaQs

Cedars-Sinai builds a healthier Los Angeles through care, community engagement and support for future learners. By welcoming all backgrounds and ideas, we help students grow and strengthen the future of scientific discovery and medical care.

Cedars-Sinai investigators are advancing a new framework for understanding ALS in living patients. By combining advanced imaging, transcriptomics and clinical data, researchers aim to identify biomarkers, define ALS subtypes and support more precise treatment strategies. https://ceda.rs/4ccPakd

Healthcare professionals, patients and caregivers are invited to the 2026 Cedars-Sinai Limb Loss Symposium on Saturday, May 2, 2026, at the Cedars-Sinai Pavilion Education Center in Los Angeles. Register today and join peers advancing the standard of limb loss care: https://bit.ly/3OoICa4

New research co-led by Cedars-Sinai Health Sciences University investigators shows that gut bacteria help protect colon tissue from injury. Published in @@cp-cell.bsky.social, the study offers insight into how intestinal disorders and therapies. Learn more: https://ceda.rs/4trpA2e

Cedars-Sinai investigators found that immune cell patterns in and around breast cancer tumors are linked to survival. Read more about this finding and other advances in our latest research tip sheet: https://ceda.rs/4btzrNx

The Youth Employment and Development Showcase celebrated students learning, growing and sharing their job shadow experiences through Cedars-Sinai NextGen programs. The future of healthcare grows stronger when young leaders can see what’s possible. Learn more: https://ceda.rs/3Og7KQH